John Stuart Patton
Founder at Aerami Therapeutics, Inc.
John Stuart Patton active positions
Companies | Position | Start | End |
---|---|---|---|
Aerami Therapeutics, Inc.
Aerami Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aerami Therapeutics, Inc. develops inhaled insulin products to treat diabetes patients. Its product Dance 501 is designed to produce consistently sized particles of liquid insulin in the form of a smooth mist, allowing the efficient and consistent delivery of insulin into the lungs in a few comfortable breaths. The company was founded by John Stuart Patton in February 9, 2009 and is headquartered in Durham, NC. | Director/Board Member | - | - |
Founder | 09/02/2009 | - | |
Chief Executive Officer | 01/01/2010 | - | |
Chairman | 01/01/2010 | - | |
Aerami Therapeutics Holdings, Inc.
Aerami Therapeutics Holdings, Inc. Medical SpecialtiesHealth Technology Dance Biopharm Holdings, Inc. engages in providing health care services. The company was founded by John Stuart Patton in 2010 and is headquartered in San Francisco, CA. | Director/Board Member | - | - |
Founder | - | - | |
Chief Executive Officer | - | 01/10/2018 | |
Chairman | - | - |
Career history of John Stuart Patton
Former positions of John Stuart Patton
Companies | Position | Start | End |
---|---|---|---|
HALOZYME THERAPEUTICS, INC. | Director/Board Member | 01/01/2000 | 06/05/2015 |
Independent Dir/Board Member | 01/01/2000 | 06/05/2015 | |
Vectura GmbH
Vectura GmbH Medical SpecialtiesHealth Technology Vectura GmbH manufactures and develops pharmaceutical therapies for airways diseases. It offers dry powder formulation technology, device technology, and development capabilities. The company was founded by Gerhard Scheuch in 1997 and is headquartered in Gemünden, Germany. | Director/Board Member | 01/01/2007 | 01/03/2014 |
Saegis Pharmaceuticals, Inc.
Saegis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Saegis Pharmaceuticals, Inc. developed drug therapeutics. Its phase II SGS742 clinical drug treated diseases such as mild cognitive impairment and attention deficit hyperactivity disorder. Its second SGS742 clinical trial provided coronary artery bypass surgery. The company was founded in 1999 and was headquartered in Half Moon Bay, CA. | Director/Board Member | - | 17/02/2009 |
NEKTAR THERAPEUTICS | Director/Board Member | 01/07/1990 | 21/11/2008 |
Chief Tech/Sci/R&D Officer | 01/07/1990 | 21/11/2008 | |
Founder | 01/07/1990 | 21/11/2008 | |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Chief Tech/Sci/R&D Officer | 01/01/1990 | 01/01/1990 |
InCarda Therapeutics, Inc.
InCarda Therapeutics, Inc. BiotechnologyHealth Technology InCarda Therapeutics, Inc. develops cardiovascular disease treatment through pulmonary delivery of established drugs. It also develops an inhaled therapy intended to treat paroxysmal atrial fibrillation. The company was founded by Narasimhan Rangachari, John S. Patton, Gregory M. Marcus and Carlos A. Schuler in 2009 and is headquartered in Newark, CA. | Director/Board Member | 01/01/2009 | - |
Founder | 01/01/2009 | - | |
University of Georgia | Corporate Officer/Principal | - | - |
Training of John Stuart Patton
University of California San Diego | Doctorate Degree |
The Pennsylvania State University | Undergraduate Degree |
University of Rhode Island | Graduate Degree |
Statistics
International
United States | 12 |
Germany | 2 |
Operational
Director/Board Member | 7 |
Founder | 4 |
Chief Tech/Sci/R&D Officer | 2 |
Sectoral
Health Technology | 9 |
Consumer Services | 5 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 2 |
---|---|
NEKTAR THERAPEUTICS | Health Technology |
HALOZYME THERAPEUTICS, INC. | Health Technology |
Private companies | 6 |
---|---|
Saegis Pharmaceuticals, Inc.
Saegis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Saegis Pharmaceuticals, Inc. developed drug therapeutics. Its phase II SGS742 clinical drug treated diseases such as mild cognitive impairment and attention deficit hyperactivity disorder. Its second SGS742 clinical trial provided coronary artery bypass surgery. The company was founded in 1999 and was headquartered in Half Moon Bay, CA. | Health Technology |
InCarda Therapeutics, Inc.
InCarda Therapeutics, Inc. BiotechnologyHealth Technology InCarda Therapeutics, Inc. develops cardiovascular disease treatment through pulmonary delivery of established drugs. It also develops an inhaled therapy intended to treat paroxysmal atrial fibrillation. The company was founded by Narasimhan Rangachari, John S. Patton, Gregory M. Marcus and Carlos A. Schuler in 2009 and is headquartered in Newark, CA. | Health Technology |
Vectura GmbH
Vectura GmbH Medical SpecialtiesHealth Technology Vectura GmbH manufactures and develops pharmaceutical therapies for airways diseases. It offers dry powder formulation technology, device technology, and development capabilities. The company was founded by Gerhard Scheuch in 1997 and is headquartered in Gemünden, Germany. | Health Technology |
Aerami Therapeutics, Inc.
Aerami Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aerami Therapeutics, Inc. develops inhaled insulin products to treat diabetes patients. Its product Dance 501 is designed to produce consistently sized particles of liquid insulin in the form of a smooth mist, allowing the efficient and consistent delivery of insulin into the lungs in a few comfortable breaths. The company was founded by John Stuart Patton in February 9, 2009 and is headquartered in Durham, NC. | Health Technology |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Aerami Therapeutics Holdings, Inc.
Aerami Therapeutics Holdings, Inc. Medical SpecialtiesHealth Technology Dance Biopharm Holdings, Inc. engages in providing health care services. The company was founded by John Stuart Patton in 2010 and is headquartered in San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- John Stuart Patton
- Experience